Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06209281
PHASE3

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

View on ClinicalTrials.gov

Summary

This study was a randomized, double-blind, placebo-controlled, multicenter, superiority design, phase III clinical trial to compare the efficacy and safety of two low-concentration atropine sulfate eye drops versus placebo in delaying myopia progression in children.

Official title: A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in Children

Key Details

Gender

All

Age Range

6 Years - 10 Years

Study Type

INTERVENTIONAL

Enrollment

526

Start Date

2022-05-13

Completion Date

2025-12

Last Updated

2025-07-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Lower dose atropine sulfate eye drops

Administer to eyes

DRUG

Low dose atropine sulfate eye drops

Administer to eyes

DRUG

placebo

Administer to eyes

Locations (1)

Eye & ENT Hospital of Fudan University

Shanghai, Shanghai Municipality, China